Vivicells International Stock Current Liabilities

VCII Stock  USD 0.0001  0.00  0.00%   
ViviCells International fundamentals help investors to digest information that contributes to ViviCells International's financial success or failures. It also enables traders to predict the movement of ViviCells Stock. The fundamental analysis module provides a way to measure ViviCells International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ViviCells International stock.
The current Total Current Liabilities is estimated to decrease to about 684.1 K.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ViviCells International Company Current Liabilities Analysis

ViviCells International's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Current Liabilities

 = 

Payables

+

Accrued Debt

More About Current Liabilities | All Equity Analysis

Current ViviCells International Current Liabilities

    
  4.12 M  
Most of ViviCells International's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ViviCells International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

ViviCells Current Liabilities Driver Correlations

Understanding the fundamental principles of building solid financial models for ViviCells International is extremely important. It helps to project a fair market value of ViviCells Stock properly, considering its historical fundamentals such as Current Liabilities. Since ViviCells International's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ViviCells International's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ViviCells International's interrelated accounts and indicators.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition

ViviCells Total Current Liabilities

Total Current Liabilities

684,076

As of now, ViviCells International's Total Current Liabilities is increasing as compared to previous years.
In accordance with the recently published financial statements, ViviCells International has a Current Liabilities of 4.12 M. This is 99.99% lower than that of the Independent Power and Renewable Electricity Producers sector and significantly higher than that of the Utilities industry. The current liabilities for all United States stocks is 99.95% higher than that of the company.

ViviCells Current Liabilities Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ViviCells International's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ViviCells International could also be used in its relative valuation, which is a method of valuing ViviCells International by comparing valuation metrics of similar companies.
ViviCells International is currently under evaluation in current liabilities category among its peers.

ViviCells Fundamentals

About ViviCells International Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ViviCells International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViviCells International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViviCells International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether ViviCells International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ViviCells International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivicells International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivicells International Stock:
Check out ViviCells International Piotroski F Score and ViviCells International Altman Z Score analysis.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Independent Power and Renewable Electricity Producers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth
(0.27)
The market value of ViviCells International is measured differently than its book value, which is the value of ViviCells that is recorded on the company's balance sheet. Investors also form their own opinion of ViviCells International's value that differs from its market value or its book value, called intrinsic value, which is ViviCells International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ViviCells International's market value can be influenced by many factors that don't directly affect ViviCells International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.